Ewing sarcoma is the second most frequent bone tumour of childhood and adolescence that
can also arise in soft tissue. Ewing sarcoma is a highly aggressive cancer, with a survival of …

Ewing sarcoma (ES) is an aggressive sarcoma of bone and soft tissue occurring at any age
with a peak incidence in adolescents and young adults. The treatment of ES relies on a …

Primary bone tumours are rare, accounting for< 0.2% of malignant neoplasms registered in
the EUROCARE (European Cancer Registry based study on survival and care of cancer …

Purpose To improve the poor prognosis of patients with primary disseminated multifocal
Ewing sarcomas (PDMES) with a dose-intense treatment concept. Patients and Methods …

Background Internationally, a single standard chemotherapy treatment for Ewing sarcoma is
not defined. Because different chemotherapy regimens were standard in Europe and the …

This document is an update of the British Sarcoma Group guidelines (2016) and provides a
reference standard for the clinical care of UK patients with primary malignant bone tumours …

Abstract Learning Objectives After completing this course, the reader will be able to:
Describe the presentation, differential diagnosis, and prognosis for patients with Ewing's …

Background The prognosis in patients with relapsed Ewing sarcoma is unfavorable. Our
investigation identifies factors predicting for the outcome following relapse. Procedure We …

PURPOSE The R2Pulm trial was conducted to evaluate the effect of busulfan-melphalan
high-dose chemotherapy with autologous stem-cell rescue (BuMel) without whole-lung …

Primary bone tumours are rare, accounting for< 0.2% of malignant tumours registered in the
EUROCARE database [1]. Different tumours have distinct patterns of incidence …